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In this issue of Structure, Zhang and colleagues present the structure of the Ego3 dimer, demonstrating that
dimerization is an obligate prerequisite in amino acid-induced TORC1 activation.The target of rapamycin (TOR) is a serine/
threonine kinase that, in response to
both internal and environmental stimuli,
coordinates growth in addition to many
other aspects of eukaryotic physiology.
TOR kinases assemble into two distinct
multiprotein complexes that are con-
served from yeast to human (Dura´n and
Hall, 2012). The activity of TOR complex
1 (TORC1), but not TORC2, is inhibited
by the macrolide rapamycin, and, as
a tool compound, rapamycin has greatly
facilitated interrogation of the signaling
events up- and downstream of TORC1.
TORC1 activity is acutely sensitive to
nutritional cues, abiotic stress, and, in
metazoans, circulating growth factors
(Zoncu et al., 2011). Signals emanating
from growth factors impinge upon the
GTPase Rheb, which, in its GTP-bound
state, activates mTORC1 (Figure 1). In
contrast, the mechanisms by which
abiotic stressors regulate TORC1/mam-
malian TORC1 (mTORC1) are not well
defined, although it is appreciated that,
in situations involving depletion of cellular
energy, activation of the AMP-activated
protein kinase results in diminished
mTORC1 activity. Of the many nutritional
cues upstream of TORC1, the best
understood, in terms of signaling, is the
branched chain amino acid leucine.
There is general concurrence now that
amino acid levels are signaled to TORC1
via the EGO complex in yeast or the struc-
turally orthologous (Kogan et al., 2010)
ragulator complex in mammalian cells.
However, precisely how amino acid abun-
dance is signaled to the EGO (ragulator)
complex and how this complex, in turn,
stimulates TORC1 activity are both hotly
debated. The EGO (ragulator) complex
is composed of Ego1 (p18/LAMTOR1),
Ego3 (p14/LAMTOR2+MP1/LAMTOR3),
and the GTPases Gtr1 (RagA and RagB)and Gtr2 (RagC and RagD) (Binda et al.,
2009; Sancak et al., 2010). The ragulator
complex additionally contains C7orf59/
LAMTOR4 and HBXIP/LAMTOR5 (Bar-
Peled et al., 2012). The business end of
the EGO (ragulator) complex is the pair
of GTPases. Curiously, it is the Gtr1GTP-
Gtr2GDP conformation of the complex
that is competent to activate TORC1,
presumably through direct interaction
with the Kog1 (raptor) subunit of TORC1
(Binda et al., 2009; Sancak et al., 2010).
Presently, at least three mechanisms
have been proposed for coupling amino
acid levels, or, more specifically, leucine
levels to the EGO (ragulator) complex
(Figure 1). The Sabatini group (Bar-Peled
et al., 2012) has proposed that amino
acids within the lumen of the lysosome
trigger a conformational switch in the
transmembrane v-ATPase complex that,
in turn, stimulates a guanosine-nucleotide
exchange (GEF) activity, inherent to
the ragulator complex, to load RagA/B
with GTP. Thus activated, the ragu-
lator complex serves to recruit mTORC1
to lysosomal membranes whereupon
mTORC1 can be activated by Rheb.
However, this does not explain a situation
documented in yeast, where TORC1 is
constitutively localized to the vacuolar
membrane, and, thus, unlike the ragulator
complex, the EGO complex appears not
to control TORC1 activity via regulation
of its localization. To reconcile these
discrepancies, the Kim and De Virgilio
groups (Han et al., 2012; Bonfils et al.,
2012) have both proposed that cyto-
plasmic leucine levels are sensed by
the leucyl-tRNA synthetase (LRS), albeit
in significantly different ways. In one
scenario, LRS was proposed to possess
a GTPase activating (GAP) activity toward
RagD, which is regulated in an amino
acid-dependent fashion (Han et al.,Structure 20, December 5, 2012 ª2012). In the other scenario, leucine levels
were suggested to regulate a conforma-
tional switch in the editing domain of
LRS, with abundant leucine promoting
interaction of the editing domain with
Gtr1 and this association promoting the
GTP-bound status of Gtr1, possibly by
protecting GTP-loaded Gtr1 from an
unknown GAP activity (Bonfils et al.,
2012). Lastly, the Hall group has proposed
that leucine, as an allosteric regulator of
glutamate dehydrogenase, activates
mTORC1 by promoting glutaminolysis
(Dura´n et al., 2012). Glutamate dehydro-
genase converts glutamate to a-ketoglu-
tarate, which, in turn, is a putatively rate-
limiting substrate for prolyl hydroxylases.
Prolyl hydroxylase subsequently acts, in
undefinedways, upstreamof the ragulator
complex.
In summary, the one thing that is clear
from these disparate proposed mecha-
nisms is that structural studies will have
a substantial role to play in the unraveling
of how amino acids signal to TORC1.
In this issue of Structure, Zhang et al.
(2012) report a high-resolution structure
of Ego3. They find that Ego3 adopts an
obligate dimeric conformation notable
for its 12-stranded anti-parallel b sheet
and a swapping of a helices from one
monomer to the other. Importantly, this
work confirms the observation made by
Kogan et al. (2010) that Ego3 shares
considerable structural similarity to the
mammalian MP1, p14 heterodimer struc-
ture, despite the modest similarity of
these proteins at the primary sequence
level and despite the fact that Kogan
et al. (2010) observed Ego3 as a tetramer,
an apparent artifact caused by harsh
crystallization conditions. Furthermore,
mutational analyses done by Zhang et al.
(2012) identify residues in Ego3 that may
be involved in the binding to Gtr1 and -2.2012 Elsevier Ltd All rights reserved 1993
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Figure 1. Amino Acid-Induced Activation of TORC1
Three mechanisms have been proposed to signal amino acid levels to TORC1 as detailed in the main text:
(i) luminal amino acids stimulate GTP loading of Rag proteins through conformational regulation of the v-
ATPase, which itself stimulates the GEF activity of the ragulator complex; (ii) leucine levels are sensed by
leucyl-tRNA synthetases (LRS, aka Cdc60 in yeast), which regulate the guanine nucleotide loading status
of Gtr1 or RagD; and (iii) glutamine and leucine levels are integrated through glutaminase (GLS) and gluta-
mate dehydrogenase (GDH) during glutaminolysis. The product of these two enzymes, a-ketoglutarate
(aKG), is a substrate for an unidentified prolyl hydroxylase (PHD), which acts upstream of the ragulator
complex. Names of mammalian ragulator proteins are written in bold. EGO (ragulator) complex compo-
nents drawn with a 3D effect indicate that high resolution structures are available for these proteins.
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PreviewsAlthough the swapping of a helices
seems to be unique to Ego3, the overall
structure and particularly the extended
b sheet are similar to the Roadblock/
LC7 (RLC7) protein superfamily. Intrigu-
ingly, several other EGO (ragulator) com-
plex components including the above-
mentioned MP1 and p14, the C-termini
of Gtr1 and Gtr2, and the recently
described C7orf59 and HBXIP proteins
also contain Roadblock domains. Indeed,
as one would predict, dimerization of Gtr1
and Gtr2 is mediated by their C-terminal
Roadblock domains (Gong et al., 2011).
It remains to be seen if Roadblock domain
proteins also function upstream of
TORC2.
It is still early in the atomic resolution of
TORC1 signaling. Structures of C7orf59,1994 Structure 20, December 5, 2012 ª2012HBXIP, and Ego1 (p18) are missing.
Next, it will be important to obtain struc-
tures of the entire EGO and/or ragulator
complexes, ideally in active and inactive
conformations. Toward this end, the
structure of a Gtr1GTP/Gtr2GDP complex
has recently been solved (Jeong et al.,
2012) and comparison to theGtr1GMPPNP /
Gtr2GMPPNP structure (Gong et al., 2011)
suggests mechanisms by which nucleo-
tide binding regulates the interaction
with TORC1. Structural interrogations
of the v-ATPase have been ongoing,
and it will be fascinating to determine
how it interacts functionally with the
ragulator complex. Last, but certainly
not least, the high resolution structure
of TORC1 itself is eagerly awaited by all
in the TOR field.Elsevier Ltd All rights reservedWhy TOR? Beyond its fundamental
role in eukaryote biology, the mTORC1
signaling pathway is clinically validated
as a drug target in cancer and will likely
soon be targeted to ameliorate symp-
toms associated with metabolic
syndrome. Identification of the signaling
events upstream of mTORC1 thus repre-
sents new nodes that can potentially be
targeted for therapeutic gain, and atomic
resolution of these signaling nodes will
help guide the synthesis of these tar-
geted therapeutics.
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